TE_25122
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | ENSG00000289174 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 171.94 |
| Counts of samples | TCGA_tumor:1372; TCGA_normal:6; GTEx:2 |
| TSS | chr12(-):88847390 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_25122.1 | ENSG00000289174 | Annoated | Non-coding | Non-coding | chr12(-):88782286,88782306,88783275,88783473,88847336,88847391 |
| teRNA_25122.2 | ENSG00000289174 | Annoated | Non-coding | Non-coding | chr12(-):88782286,88782306,88783275,88783473,88847251,88847391 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
